HDAC3 and HDAC7 Have Opposite Effects on Osteoclast Differentiation
Open Access
- 1 April 2011
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 286 (14), 12056-12065
- https://doi.org/10.1074/jbc.m110.216853
Abstract
No abstract availableKeywords
This publication has 45 references indexed in Scilit:
- Histone Deacetylase 3 Depletion in Osteo/Chondroprogenitor Cells Decreases Bone Density and Increases Marrow FatPLOS ONE, 2010
- Novel histone deacetylase inhibitors in clinical trials as anti-cancer agentsJournal of Hematology & Oncology, 2010
- Trichostatin A inhibits osteoclastogenesis and bone resorption by suppressing the induction of c-Fos by RANKLEuropean Journal of Pharmacology, 2009
- Development of Histone Deacetylase Inhibitors as Therapeutics for Neurological DiseaseFuture Neurology, 2009
- Histone Deacetylase 7 Associates With Runx2 and Represses Its Activity During Osteoblast Maturation in a Deacetylation-Independent MannerJournal of Bone and Mineral Research, 2008
- Eos, MITF, and PU.1 Recruit Corepressors to Osteoclast-Specific Genes in Committed Myeloid ProgenitorsMolecular and Cellular Biology, 2007
- Trichostatin A-mediated upregulation of p21WAF1 contributes to osteoclast apoptosisExperimental & Molecular Medicine, 2007
- Microphthalmia-associated Transcription Factor Interactions with 14-3-3 Modulate Differentiation of Committed Myeloid PrecursorsMolecular Biology of the Cell, 2006
- CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTSAnnual Review of Pharmacology and Toxicology, 2005
- Osteoclast differentiation and activationNature, 2003